Your prediction
Swedish Orphan Biovitrum Ab Stock
Swedish Orphan Biovitrum Ab dominated the market today, gaining €2.66 (7.920%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Swedish Orphan Biovitrum Ab stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Swedish Orphan Biovitrum Ab in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Swedish Orphan Biovitrum Ab vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Swedish Orphan Biovitrum Ab | 7.920% | 13.458% | 16.881% | 25.673% | 18.555% | 76.368% | 121.465% |
| Almirall S.A. | 0.460% | 5.008% | -1.065% | 40.011% | 0.464% | 41.151% | 18.505% |
| Orion Corp. B | 0.490% | 2.331% | 14.455% | 38.000% | 13.292% | 46.571% | 89.016% |
| Sihuan Pharmaceutical Holdings Group Ltd. | 2.940% | 5.422% | 23.239% | 133.333% | 33.588% | 36.719% | -29.435% |